Genomic characterization of liver metastases from colorectal cancer patients

Metastatic dissemination is the most frequent cause of death of sporadic colorectal cancer (sCRC) patients. Genomic abnormalities which are potentially characteristic of such advanced stages of the disease are complex and so far, they have been poorly described and only partially understood. We evaluated the molecular heterogeneity of sCRC tumors based on simultaneous assessment of the overall GEP of both coding mRNA and non-coding RNA genes in primary sCRC tumor samples from 23 consecutive patients and their paired liver metastases. Liver metastases from the sCRC patients analyzed, systematically showed deregulated transcripts of those genes identified as also deregulated in their paired primary colorectal carcinomas. However, some transcripts were found to be specifically deregulated in liver metastases (vs. non-tumoral colorectal tissues) while expressed at normal levels in their primary tumors, reflecting either an increased genomic instability of metastatic cells or theiradaption to the liver microenvironment. Newly deregulated metastatic transcripts included overexpression of APOA1, HRG, UGT2B4, RBP4 and ADH4 mRNAS and the miR-3180-3p, miR-3197, miR-3178, miR-4793 and miR-4440 miRNAs, together with decreased expression of the IGKV1-39, IGKC, IGKV1-27, FABP4 and MYLK mRNAS and the miR-363, miR-1, miR-143, miR-27b and miR-28-5p miRNAs. Canonical pathways found to be specifically deregulated in liver metastatic samples included multiple genes related with intercellular adhesion and the metastatic processes (e.g., IGF1R, PIK3CA, PTEN and EGFR), endocytosis (e.g., the PDGFRA, SMAD2, ERBB3, PML and FGFR2), and the cell cycle (e.g., SMAD2, CCND2, E2F5 and MYC). Our results also highlighted the activation of genes associated with the TGFβ signaling pathway, -e.g. RHOA, SMAD2, SMAD4, SMAD5, SMAD6, BMPR1A, SMAD7 and MYC-, which thereby emerge as candidate genes to play an important role in CRC tumor metastasis.

[1]  Axel Benner,et al.  A Systematic Approach to Defining the microRNA Landscape in Metastasis. , 2015, Cancer research.

[2]  He Zhou,et al.  miR‑20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis. , 2014, Molecular medicine reports.

[3]  Jie Hong,et al.  Calcium Prevents Tumorigenesis in a Mouse Model of Colorectal Cancer , 2011, PloS one.

[4]  Kristin L. Sainani,et al.  Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker , 2011, PloS one.

[5]  Xin Li,et al.  miR-20a targets BNIP2 and contributes chemotherapeutic resistance in colorectal adenocarcinoma SW480 and SW620 cell lines. , 2011, Acta biochimica et biophysica Sinica.

[6]  MicroRNA-490-3p inhibits colorectal cancer metastasis by targeting TGFβR1 , 2015, BMC Cancer.

[7]  A. Patócs.  TGF-[beta] signaling and the microRNA machinery , 2013 .

[8]  Tongbin Li,et al.  miRecords: an integrated resource for microRNA–target interactions , 2008, Nucleic Acids Res..

[9]  K. Ohuchida,et al.  MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. , 2011, Surgery.

[10]  R. Korstanje,et al.  Proprotein convertases in high-density lipoprotein metabolism , 2013, Biomarker Research.

[11]  Rod A Lea,et al.  Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level , 2008, BMC Cancer.

[12]  S. Haan,et al.  Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer , 2014, British Journal of Cancer.

[13]  A I Saeed,et al.  TM4: a free, open-source system for microarray data management and analysis. , 2003, BioTechniques.

[14]  S. Bhattacharyya,et al.  Insulin-like growth factor-1 prevents miR-122 production in neighbouring cells to curtail its intercellular transfer to ensure proliferation of human hepatoma cells , 2014, Nucleic acids research.

[15]  G. Pedrazzi,et al.  PTEN status in advanced colorectal cancer treated with cetuximab , 2009, British Journal of Cancer.

[16]  Javier De Las Rivas,et al.  GATExplorer: Genomic and Transcriptomic Explorer; mapping expression probes to gene loci, transcripts, exons and ncRNAs , 2010, BMC Bioinformatics.

[17]  Dong-Hyung Cho,et al.  A nineteen gene‐based risk score classifier predicts prognosis of colorectal cancer patients , 2014, Molecular oncology.

[18]  Qiang Wang,et al.  FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer , 2015, Cancer biology & therapy.

[19]  J. Lutterbaugh,et al.  PMEPA1, a transforming growth factor-beta-induced marker of terminal colonocyte differentiation whose expression is maintained in primary and metastatic colon cancer. , 2003, Cancer research.

[20]  S. Waldman,et al.  GUCY2C lysosomotropic endocytosis delivers immunotoxin therapy to metastatic colorectal cancer , 2014, Oncotarget.

[21]  Shung-Haur Yang,et al.  Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers , 2015, Journal of surgical oncology.

[22]  Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer , 2014, Journal of Applied Genetics.

[23]  M. Setou,et al.  Effect of miR‐122 and its target gene cationic amino acid transporter 1 on colorectal liver metastasis , 2013, Cancer science.

[24]  Robert A. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer (Nature (2007) 449, (682-688)) , 2008 .

[25]  R. Kelley,et al.  Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. , 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

[26]  L. Fu,et al.  Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients. , 2012, Biochemical and biophysical research communications.

[27]  A. Kalmár,et al.  Cell Free DNA of Tumor Origin Induces a ‘Metastatic’ Expression Profile in HT-29 Cancer Cell Line , 2015, PloS one.

[28]  Takuji Tanaka,et al.  Protein expression analysis of inflammation-related colon carcinogenesis , 2009, Journal of carcinogenesis.

[29]  Xue-Li Zhang,et al.  miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3. , 2015, International journal of clinical and experimental pathology.

[30]  Zhihua Liu,et al.  MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines* , 2010, The Journal of Biological Chemistry.

[31]  Chang-Ming Jan,et al.  The Prognostic Significance of Total Lymph Node Harvest in Patients with T2–4N0M0 Colorectal Cancer , 2007, Journal of Gastrointestinal Surgery.

[32]  F. Greene.  Current TNM staging of colorectal cancer. , 2007, The Lancet. Oncology.

[33]  A. Pandurangan,et al.  Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[34]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[35]  Joan Figueras,et al.  Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection. , 2007, Carcinogenesis.

[36]  Stefania Bortoluzzi,et al.  Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis , 2013, BMC Genomics.

[37]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Ferracin,et al.  MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab , 2015, Oncotarget.

[39]  Haiyu Shen,et al.  RETRACTED ARTICLE: MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition , 2015, Tumor Biology.

[40]  Hiroshi Tanaka,et al.  Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer , 2011, Clinical Cancer Research.

[41]  Aditi Chatterjee,et al.  Plasma Proteome Database as a resource for proteomics research: 2014 update , 2013, Nucleic Acids Res..

[42]  Xiayu Li,et al.  New prognosis biomarkers identified by dynamic proteomic analysis of colorectal cancer. , 2012, Molecular bioSystems.

[43]  E. Lundberg,et al.  Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.

[44]  J. Chirgwin,et al.  The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone. , 2015, Cancer cell.

[45]  K R Gabriel,et al.  Biplots in biomedical research. , 1990, Statistics in medicine.

[46]  M. Kagnoff,et al.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. , 1995, The Journal of clinical investigation.

[47]  MiR-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer , 2014, BMC Cancer.

[48]  V. Moreno,et al.  Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors. , 2015, The oncologist.

[49]  C. Fontanillo,et al.  Unique genetic profile of sporadic colorectal cancer liver metastasis versus primary tumors as defined by high-density single-nucleotide polymorphism arrays , 2012, Modern Pathology.

[50]  Yong Liu,et al.  HLJ1 is a novel biomarker for colorectal carcinoma progression and overall patient survival. , 2014, International journal of clinical and experimental pathology.

[51]  L. Hunyady,et al.  Crosstalk between TGF-β signaling and the microRNA machinery. , 2012, Trends in pharmacological sciences.

[52]  E. E. Gresch.  Genetic Alterations During Colorectal-Tumor Development , 1989 .

[53]  B. Liu,et al.  The Transition from Proliferation to Differentiation in Colorectal Cancer Is Regulated by the Calcium Activated Chloride Channel A1 , 2013, PloS one.

[54]  A. Órfão,et al.  Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas , 2015, Oncotarget.

[55]  Qun Qian,et al.  MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1 , 2014, Oncology letters.

[56]  Norbert Gretz,et al.  miRWalk - Database: Prediction of possible miRNA binding sites by "walking" the genes of three genomes , 2011, J. Biomed. Informatics.

[57]  A. Schetter,et al.  Identification of a metastasis-specific MicroRNA signature in human colorectal cancer. , 2015, Journal of the National Cancer Institute.

[58]  K. Shirouzu,et al.  Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer. , 2012, Anticancer research.

[59]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.